Bavendiek U - Search Results

1

Mitogen-activated protein kinase-activated protein kinase 2 deficiency reduces insulin sensitivity in high-fat diet-fed mice.

de Boer JF, Dikkers A, Jurdzinski A, von Felden J, Gaestel M, Bavendiek U, Tietge UJ. de Boer JF, et al. Among authors: bavendiek u. PLoS One. 2014 Sep 18;9(9):e106300. doi: 10.1371/journal.pone.0106300. eCollection 2014. PLoS One. 2014. PMID: 25233471 Free PMC article.

2

Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man.

Luchtefeld M, Schunkert H, Stoll M, Selle T, Lorier R, Grote K, Sagebiel C, Jagavelu K, Tietge UJ, Assmus U, Streetz K, Hengstenberg C, Fischer M, Mayer B, Maresso K, El Mokhtari NE, Schreiber S, Müller W, Bavendiek U, Grothusen C, Drexler H, Trautwein C, Broeckel U, Schieffer B. Luchtefeld M, et al. Among authors: bavendiek u. J Exp Med. 2007 Aug 6;204(8):1935-44. doi: 10.1084/jem.20070120. Epub 2007 Jul 30. J Exp Med. 2007. PMID: 17664290 Free PMC article.

3

Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic mice.

Jagavelu K, Tietge UJ, Gaestel M, Drexler H, Schieffer B, Bavendiek U. Jagavelu K, et al. Among authors: bavendiek u. Circ Res. 2007 Nov 26;101(11):1104-12. doi: 10.1161/CIRCRESAHA.107.156075. Epub 2007 Sep 20. Circ Res. 2007. PMID: 17885219

4

Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice.

Schuett H, Oestreich R, Waetzig GH, Annema W, Luchtefeld M, Hillmer A, Bavendiek U, von Felden J, Divchev D, Kempf T, Wollert KC, Seegert D, Rose-John S, Tietge UJ, Schieffer B, Grote K. Schuett H, et al. Among authors: bavendiek u. Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):281-90. doi: 10.1161/ATVBAHA.111.229435. Epub 2011 Nov 10. Arterioscler Thromb Vasc Biol. 2012. PMID: 22075248

5

Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cells.

Jagielska J, Kapopara PR, Salguero G, Scherr M, Schütt H, Grote K, Schieffer B, Bavendiek U. Jagielska J, et al. Among authors: bavendiek u. Arterioscler Thromb Vasc Biol. 2012 May;32(5):1280-8. doi: 10.1161/ATVBAHA.111.243477. Epub 2012 Feb 16. Arterioscler Thromb Vasc Biol. 2012. PMID: 22345171

6

Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury.

Kapopara PR, von Felden J, Soehnlein O, Wang Y, Napp LC, Sonnenschein K, Wollert KC, Schieffer B, Gaestel M, Bauersachs J, Bavendiek U. Kapopara PR, et al. Among authors: bavendiek u. Thromb Haemost. 2014 Dec;112(6):1264-76. doi: 10.1160/TH14-02-0174. Epub 2014 Aug 14. Thromb Haemost. 2014. PMID: 25120198

7

MAP-Kinase Activated Protein Kinase 2 Links Endothelial Activation and Monocyte/macrophage Recruitment in Arteriogenesis.

Limbourg A, von Felden J, Jagavelu K, Krishnasamy K, Napp LC, Kapopara PR, Gaestel M, Schieffer B, Bauersachs J, Limbourg FP, Bavendiek U. Limbourg A, et al. Among authors: bavendiek u. PLoS One. 2015 Oct 2;10(10):e0138542. doi: 10.1371/journal.pone.0138542. eCollection 2015. PLoS One. 2015. PMID: 26431421 Free PMC article.

8

Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice.

Napp LC, Jabs O, Höckelmann A, Dutzmann J, Kapopara PR, Sedding DG, Gaestel M, Bauersachs J, Bavendiek U. Napp LC, et al. Among authors: bavendiek u. Vasc Cell. 2016 Oct 21;8:4. doi: 10.1186/s13221-016-0038-2. eCollection 2016. Vasc Cell. 2016. PMID: 27790365 Free PMC article.

9

Erratum to: 'Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice'.

Napp LC, Jabs O, Höckelmann A, Dutzmann J, Kapopara PR, Sedding DG, Gaestel M, Bauersachs J, Bavendiek U. Napp LC, et al. Among authors: bavendiek u. Vasc Cell. 2016 Dec 23;9:1. doi: 10.1186/s13221-016-0039-1. eCollection 2017. Vasc Cell. 2016. PMID: 28228935 Free PMC article.

10

Digitoxin elicits anti-inflammatory and vasoprotective properties in endothelial cells: Therapeutic implications for the treatment of atherosclerosis?

Jagielska J, Salguero G, Schieffer B, Bavendiek U. Jagielska J, et al. Among authors: bavendiek u. Atherosclerosis. 2009 Oct;206(2):390-6. doi: 10.1016/j.atherosclerosis.2009.03.019. Epub 2009 Mar 25. Atherosclerosis. 2009. PMID: 19446813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page